KA
CVS icon

Kozak & Associates’s CVS Health CVS Stock Holding History

Kozak & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.9K Buy
66
+1
+2% +$89 ﹤0.01% 289
2026
Q1 		$5.1K Hold
65
– – ﹤0.01% 309
2025
Q4 		$5.2K Hold
65
– – ﹤0.01% 302
2025
Q3 		$5.07K Buy
65
+1
+2% +$69 ﹤0.01% 306
2025
Q2 		$4.29K Hold
64
– – ﹤0.01% 303
2025
Q1 		$4.41K Buy
64
+1
+2% +$60 ﹤0.01% 302
2024
Q4 		$2.89K Sell
63
-1,032
-94% -$57.9K ﹤0.01% 337
2024
Q3 		$71.2K Buy
1,095
+12
+1% +$700 0.02% 117
2024
Q2 		$61.4K Sell
1,083
-2
-0.2% -$125 0.02% 117
2024
Q1 		$62.4K Sell
1,085
-868
-44% -$66.3K 0.02% 120
2023
Q4 		$151K Sell
1,953
-2,683
-58% -$191K 0.05% 83
2023
Q3 		$324K Sell
4,636
-269
-5% -$19.1K 0.12% 59
2023
Q2 		$342K Buy
4,905
+83
+2% +$5.91K 0.14% 63
2023
Q1 		$358K Buy
4,822
+12
+0.2% +$1.01K 0.16% 60
2022
Q4 		$448K Buy
4,810
+9
+0.2% +$868 0.22% 41
2022
Q3 		$425K Buy
4,801
+1,664
+53% +$165K 0.27% 39
2022
Q2 		$291K Buy
3,137
+9
+0.3% +$878 0.19% 52
2022
Q1 		$326K Hold
3,128
– – 0.21% 56
2021
Q4 		$326K Buy
3,128
+334
+12% +$30.9K 0.21% 56
2021
Q3 		$261K Buy
+2,794
New +$234K 0.15% 67

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Kozak & Associates's CVS Position: Q2 2026 in Review

Kozak & Associates increased its CVS Health (CVS) stake by 1.5% in Q2 2026, buying an estimated $89 and bringing the position to 66 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Kozak & Associates first reported a position in CVS in Q3 2021 and has held it in 20 quarters since. The position peaked at $448K in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Kozak & Associates held 66 shares of CVS Health worth $6.9K as of Q2 2026.
  • Kozak & Associates bought 1 CVS Health share in Q2 2026, an estimated $89.
  • CVS Health made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #289 holding.
  • Kozak & Associates first reported a position in CVS Health in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's CVS Health position peaked at $448K in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.